The Education You Expect From The Experts You Know.

It is essential for you to keep up with the newest scientific advancements and stay abreast of the rapid pace of change in the field. We must be dedicated to researching and evaluating the latest discoveries so we can incorporate the best treatments into our practices.

At the 26th Annual World Congress on Gastrointestinal Cancer you will be exposed to advanced research and innovations impacting the field of GI oncology. Anticipate engaging case-based panels in each therapy area, facilitated by a diverse faculty and anchored by a captivating "State of the Science and Clinical Care" Talk, which will set the stage for an in-depth exploration of the therapy area under discussion.

It is time to radically change our patients lives. 

Join us in Barcelona 3-6 July 2024. 

Highlights

  • 4
    Days
  • 15+
    Sessions
  • 70+
    Expert Faculty
  • 1
    Breathtaking City - Barcelona

Who Attends World GI Congress

The Congress is specifically designed for practicing clinicians dedicated to enhancing their knowledge and advancing the treatment and management of cancers of the gastrointestinal tract.

Physicians, Medical Oncologists, Radiation Oncologists, Pathologists, Hepatologists, Gastroenterologists, Surgeons, Clinical Researchers, Trainees/Residents/Students

Globally Diverse Scientific Committee and Faculty

Composed of some of the world’s leading specialists in gastrointestinal cancer, the 26th World Congress on Gastrointestinal Cancer's Scientific Committee has developed a comprehensive programme to ensure you are up-to-date on the most advanced treatments and emerging data in this rapidly advancing scientific field.

Forging Scientific Breakthroughs

Through lectures, tandem talks, debates, keynote lectures, and abstract presentations, the Scientific Programme examines a range of gastrointestinal malignancies and offers a mix of dynamic education and exchange.

Hot Topics You Can Participate In:

  • Keynote: Global Health Perspective: Cost and Sustainability of Cancer Drugs 

  • Surgical Innovations in Pancreatic Cancer (Prehabilitation and Robotics) 

  • Resection of HCC: Progress from 2014 to 2024 

  • Managing the Timely Determination of Clinically Useful Molecular markers in Gastric/Gastroesophageal Junction Cancers (PDL-1 CPS, HER2, FGFR2, CLDN18.2, MSI, and DKK1) 

  • The Power of Tumor-Informed Liquid Biopsy in Stage II and III Colon Cancer 

  • Neuroendocrine Malignancies 

  • Artificial Intelligence: Current and Emerging Applications in Molecular Classification of CRC 

  • Novel Immunotherapy Approaches to MSS CRC 

  • How to Develop Your Career in Oncology? 

  • How to Design and Interpret Clinical Trials? 

Back to top